PauloSaldiGarciaMDFCAP, FASCP, FUSCAP
Pathology • Pittsburgh, PACytopathology, Gastrointestinal & Hepatobiliary Pathology, Anatomic Pathology, Clinical Pathology
Clinical Assistant Professor
Dr. Garcia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UPMC Passavant
9100 Babcock Blvd
Pittsburgh, PA 15237Phone+1 412-748-3233
Summary
- Dr. Paulo Garcia is a board-certified pathologist in Pittsburgh, PA. He received his medical degree from University of Nevada School of Medicine and has been in practice 2 years. He specializes in cytopathology, GI & hepatobiliary pathology, pancreaticobiliary pathology, anatomic pathology, and clinical pathology.
Education & Training
Virginia Commonwealth University Health SystemFellowship, Cytopathology, 2020 - 2021- Virginia Commonwealth University Health SystemResidency, Pathology-Anatomic and Clinical, 2016 - 2020
University of Nevada, Reno School of MedicineClass of 2016
Certifications & Licensure
PA State Medical License 2021 - 2024
VA State Medical License 2020 - 2022- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- UNSEG: unsupervised segmentation of cells and their nuclei in complex tissue samples.Bogdan Kochetov, Phoenix D Bell, Paulo S Garcia, Akram S Shalaby, Rebecca Raphael
Communications Biology. 2024-08-30 - 2 citationsUNSEG: unsupervised segmentation of cells and their nuclei in complex tissue samples.Bogdan Kochetov, Phoenix Bell, Paulo S Garcia, Akram S Shalaby, Rebecca Raphael
Biorxiv. 2024-04-23 - 3 citationsA Synoptic Reporting System to Monitor Bone Marrow Aspirate and Biopsy Quality.Roger S. Riley, Paras Gandhi, Susan E Harley, Paulo Garcia, Justin B. Dalton
Journal of Pathology Informatics. 2021-01-01
Press Mentions
Area 23: Lil Sugar, the Villain Protecting Kids’ HealthOctober 6th, 2021- Accelerating the Pace of Engineered Cell Therapies, from Lab to BedsideMay 6th, 2021
- Greg Crescenzi Joins Kytopen as Chief Commercial Officer to Drive Discovery, Development and Delivery of Curative Cellular TherapeuticsMarch 30th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
